May 4, 2026

Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center were the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The case of the complete remission, which had been previously published in the Neurosurgery Journal, was verified as the first in the world with a novel immunotherapy regimen detailed in a new publication in the journal Surgical Neurology International.

April 17, 2026

University of Cincinnati Cancer Center researchers will present abstracts at the American Association for Cancer Research Annual Meeting 2026 April 17 to 22 in San Diego.

April 17, 2026

University of Cincinnati researchers will present abstracts at the 2026 American Academy of Neurology Annual Meeting April 18 to 22 in Chicago.

April 14, 2026

A case report led by University of Cincinnati researchers has been recognized as the 2026 American Academy of Neurology (AAN) Resident & Fellow Section Writing Award Winner.

April 13, 2026

The University of Cincinnati's Shana Feibel, DO, was featured in a Parents magazine article discussing how to help your child who is an empath manage their big feelings.

April 1, 2026

The University of Cincinnati's John Winhusen was featured in a Rolling Stone article discussing the potential for GLP-1s to treat substance abuse disorders.

March 30, 2026

University of Cincinnati researchers, funded by the NIH, are studying how GLP-1 drugs may help prevent Alzheimer’s disease by analyzing real-world data from patients with mild cognitive impairment. Learn more about this groundbreaking UC Alzheimer’s research.

March 24, 2026

The University of Cincinnati's Emerlee Timmerman, MD, was featured in a Women's Health article discussing exercises that benefit your brain as well as your body.

March 23, 2026

MedPage Today highlighted research led by the University of Cincinnati's John Winhusen published in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue.

March 20, 2026

Research published in the journal Cell Reports led by the University of Cincinnati’s Jiajie Diao, PhD, reshapes the field’s fundamental understanding of lysosomal acidification.